Treatment of Highly Drug-Resistant Pulmonary Tuberculosis
2020 · New England Journal of Medicine · 962 citations
https://doi.org/10.1056/nejmoa1901814
E
Erica Egizi
TB Alliance(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
19
Papers
1.7K
Citations
7
h-index
7
i10-index
Erica Egizi is an academic researcher from TB Alliance. The author has contributed to research in topics: Tuberculosis Research and Epidemiology & Pharmacovigilance and Adverse Drug Reactions & Pneumonia and Respiratory Infections. The author has an h-index of 7, co-authored 17 publications.
Papers by this author
worksBedaquiline–Pretomanid–Linezolid Regimens for Drug-Resistant Tuberculosis
2022 · New England Journal of Medicine · 507 citations
https://doi.org/10.1056/nejmoa2119430
The Safety and Tolerability of Linezolid in Novel Short-Course Regimens Containing Bedaquiline, Pretomanid, and Linezolid to Treat Rifampicin-Resistant Tuberculosis: An Individual Patient Data Meta-analysis
2023 · Clinical Infectious Diseases · 32 citations
https://doi.org/10.1093/cid/ciad653
Protocol for a phase 2, partially blinded, randomized trial assessing the safety and efficacy of sorfequiline or bedaquiline in combination with pretomanid and linezolid in adult participants with newly diagnosed, drug-sensitive, smear-positive pulmonary tuberculosis (NC-009)
2026 · Trials · 0 citations
https://doi.org/10.1186/s13063-025-09413-5
Additional file 3 of Protocol for a phase 2, partially blinded, randomized trial assessing the safety and efficacy of sorfequiline or bedaquiline in combination with pretomanid and linezolid in adult participants with newly diagnosed, drug-sensitive, smear-positive pulmonary tuberculosis (NC-009)
2026 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.31246110
Additional file 4 of Protocol for a phase 2, partially blinded, randomized trial assessing the safety and efficacy of sorfequiline or bedaquiline in combination with pretomanid and linezolid in adult participants with newly diagnosed, drug-sensitive, smear-positive pulmonary tuberculosis (NC-009)
2026 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.31246113
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat